Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial

Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial

10.1159/000503713

Saved in:

Bibliographic Details
Main Authors:	Bakris, George L, Agarwal, Rajiv, Anker, Stefan D, Pitt, Bertram, Ruilope, Luis M, Nowack, Christina, Kolkhof, Peter, Ferreira, Anna C, Schloemer, Patrick, Filippatos, Gerasimos, FIGARO-DKD investigators
Other Authors:	MEDICINE
Format:	Article
Language:	English
Published:	KARGER 2023
Subjects:	Science & Technology Life Sciences & Biomedicine Urology & Nephrology Outcomes Clinical Kidney Mineralocorticoid Diabetes Aldosterone MINERALOCORTICOID RECEPTOR ALDOSTERONE BLOCKADE HEART-FAILURE DOUBLE-BLIND BAY 94-8862 ANTAGONIST SPIRONOLACTONE ALBUMINURIA NEPHROPATHY MORTALITY
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/246026
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

Description
Summary:	10.1159/000503713